Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.

Bloom S, Kemp W, Nicoll A, Roberts SK, Gow P, Dev A, Bell S, Sood S, Kronborg I, Knight V, Lewis D, Lubel J.

J Hepatol. 2018 Sep;69(3):575-583. doi: 10.1016/j.jhep.2018.04.013. Epub 2018 Apr 28.

PMID:
29709676
2.

Outreach screening of drug users for cirrhosis with transient elastography.

Moessner BK, Jørgensen TR, Skamling M, Vyberg M, Junker P, Pedersen C, Christensen PB.

Addiction. 2011 May;106(5):970-6. doi: 10.1111/j.1360-0443.2010.03246.x. Epub 2010 Dec 23. Erratum in: Addiction. 2012 Jan;107(1):236.

PMID:
21182552
3.

Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.

Wang JH, Yen YH, Yao CC, Hung CH, Chen CH, Hu TH, Lee CM, Lu SN.

Liver Int. 2016 Dec;36(12):1793-1799. doi: 10.1111/liv.13179. Epub 2016 Jun 28.

PMID:
27254286
4.

Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B.

Wong GL, Chan HL, Yu Z, Wong CK, Leung C, Ho PP, Chan CY, Chung VC, Chan ZC, Tse YK, Chim AM, Lau TK, Chan HY, Tse CH, Wong VW.

J Gastroenterol Hepatol. 2015 Mar;30(3):582-90. doi: 10.1111/jgh.12779.

PMID:
25252074
5.

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.

J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.

PMID:
20932598
6.

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.

Petta S, Cammà C, DI Marco V, Calvaruso V, Enea M, Bronte F, Butera G, Cabibi D, Craxì A.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):603-13. doi: 10.1111/j.1365-2036.2009.04079.x. Epub 2009 Jun 25.

7.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

8.

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Imamura J, Goto T, Kanai F, Kato N, Ikeda H, Shiina S, Kawabe T, Omata M.

Hepatology. 2009 Jun;49(6):1954-61. doi: 10.1002/hep.22870.

PMID:
19434742
9.

Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.

Gonzalez FA, Van den Eynde E, Perez-Hoyos S, Navarro J, Curran A, Burgos J, Falcó V, Ocaña I, Ribera E, Crespo M.

HIV Med. 2015 Apr;16(4):211-8. doi: 10.1111/hiv.12197. Epub 2014 Sep 18.

10.

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.

Macías J, Camacho A, Von Wichmann MA, López-Cortés LF, Ortega E, Tural C, Ríos MJ, Merino D, Téllez F, Márquez M, Mancebo M, Pineda JA.

AIDS. 2013 Oct 23;27(16):2541-9. doi: 10.1097/QAD.0b013e32836381f3.

PMID:
23736148
11.

Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.

Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, Wang JH.

Liver Int. 2013 May;33(5):756-61. doi: 10.1111/liv.12118. Epub 2013 Feb 14.

PMID:
23405889
12.

Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.

Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G.

Can J Gastroenterol. 2010 Nov;24(11):661-70.

13.

Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy.

Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, Kikuchi T, Hirano K, Iijima K, Wada R, Ichida T.

J Gastroenterol Hepatol. 2014 Jan;29(1):137-43. doi: 10.1111/jgh.12401.

PMID:
24117602
14.

The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.

Chon YE, Jung ES, Park JY, Kim DY, Ahn SH, Han KH, Chon CY, Jung KS, Kim SU.

J Clin Gastroenterol. 2012 Jul;46(6):518-25. doi: 10.1097/MCG.0b013e31825079f1.

PMID:
22688146
15.

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.

Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, Chermak F, Hubert IF, Merrouche W, Oberti F, de Lédinghen V, Calès P.

Hepatology. 2014 Jul;60(1):65-76. doi: 10.1002/hep.27069.

PMID:
24519328
16.

Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.

Abdelaziz AO, Shousha HI, Said EM, Soliman ZA, Shehata AA, Nabil MM, Abdelmaksoud AH, Elbaz TM, Abdelsalam FM.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1384-1388. doi: 10.1097/MEG.0000000000001196.

PMID:
30179227
17.

Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.

Ziol M, Kettaneh A, Ganne-Carrié N, Barget N, Tengher-Barna I, Beaugrand M.

Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1261-8. doi: 10.1097/MEG.0b013e32832a20f5.

PMID:
19478678
18.

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases.

Ducancelle A, Leroy V, Vergniol J, Sturm N, Le Bail B, Zarski JP, Nguyen Khac E, Salmon D, de Ledinghen V, Calès P.

J Clin Gastroenterol. 2017 Aug;51(7):639-649. doi: 10.1097/MCG.0000000000000788.

PMID:
28692443
19.

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

Wong GL, Chan HL, Wong CK, Leung C, Chan CY, Ho PP, Chung VC, Chan ZC, Tse YK, Chim AM, Lau TK, Wong VW.

J Hepatol. 2014 Feb;60(2):339-45. doi: 10.1016/j.jhep.2013.09.029. Epub 2013 Oct 12.

PMID:
24128413
20.

FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.

Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Moussalli J, Lebray P, Thabut D, Ratziu V.

Clin Res Hepatol Gastroenterol. 2011 Nov;35(11):720-30. doi: 10.1016/j.clinre.2011.07.003. Epub 2011 Aug 17.

PMID:
21852224

Supplemental Content

Support Center